Gilead Sciences, Inc. (GIS.DE) XETRA

107.06

+1.68(+1.59%)

Updated at December 23 05:35PM

Currency In EUR

Valuation

Market Cap115.69B
Enterprise Value132.41B
P/E Ratio19.26
PEG Ratio0.67
Price/Sales Ratio5.36
Price/Book Ratio7.28
Enterprise/Revenue5.14
Enterprise/EBITDA11.73

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.28
Operating Margin0.36

Management Effectiveness

Return On Assets0.14
Return On Equity0.41

Income Statement

Revenue28.75B
Revenue/Share23.4
Gross Profit22.5B
EBITDA4.43B
Net Income480M
Diluted EPS0.38

Balance Sheet

Total Cash7.35B
Total Cash/Share7.53
Total Debt24.94B
Total Debt/Equity0.13
Current Ratio1.53
Book Value Per Share17.26

Price History

52-Week Change18.56
52-Week High111.84
52-Week Low82.04
Moving Average 50 Days105.51
Moving Average 200 Days98.48

Statistics

Average Volume1,040
Shares Outstanding1.24B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate3.16
Trailing Annual Dividend Yield2.51
Payout Ratio0.61
Last Split Factor2:1
Last Split DateJanuary 28, 2013